Insider Transactions in Q4 2024 at Verve Therapeutics, Inc. (VERV)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2024
|
Sekar Kathiresan Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
30,000
+21.28%
|
-
|
|
Dec 04
2024
|
Sekar Kathiresan Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
30,000
-8.49%
|
-
|
|
Dec 02
2024
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
555
-9.35%
|
$2,775
$5.64 P/Share
|
|
Nov 29
2024
|
Allison Dorval Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+24.01%
|
-
|